Pro Medicus Limited (PMCUF)

Pro Medicus Income Statement

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Operating Revenue	240.57	212.98	161.5	124.9	93.46	67.88
Other Revenue	0.57	-	-	-	-	0.18
Revenue	241.13	212.98	161.5	124.9	93.46	68.06
Revenue Growth (YoY)	28.14%	31.87%	29.30%	33.64%	37.31%	19.79%
Cost of Revenue	0.32	0.31	0.3	0.54	0.47	0.49
Gross Profit	240.81	212.67	161.2	124.36	93	67.57
Selling, General & Admin	55.47	47.04	38.7	31.07	21.56	16.76
Other Operating Expenses	-150.36	0.61	1.21	1.29	2.8	0.99
Operating Expenses	-87.15	54.88	48.41	40.28	31.68	24.94
Operating Income	327.97	157.79	112.79	84.08	61.31	42.63
Interest & Investment Income	7.56	7.56	4.83	2.43	0.65	-
Currency Exchange Gain (Loss)	-2.18	-2.03	-1.12	-0.39	1.12	0.24
Other Non Operating Income (Expenses)	-	-	-	0	-	-
Pretax Income	333.34	163.31	116.5	86.13	63.08	42.87
Income Tax Expense	98.65	48.1	33.7	25.48	18.64	12.02
Net Income	234.7	115.22	82.79	60.65	44.44	30.85
Net Income to Common	234.7	115.22	82.79	60.65	44.44	30.85
Net Income Growth	138.78%	39.16%	36.52%	36.47%	44.06%	33.69%
Shares Outstanding (Basic)	104	104	104	104	104	104
Shares Outstanding (Diluted)	105	105	105	105	105	105
Shares Change (YoY)	0.04%	0.01%	0.06%	0.01%	-0.01%	0.13%
EPS (Basic)	2.25	1.10	0.79	0.58	0.43	0.30
EPS (Diluted)	2.24	1.10	0.79	0.58	0.42	0.29
EPS Growth	138.73%	39.19%	36.38%	36.47%	44.07%	33.48%
Free Cash Flow	127.37	110.89	81.67	62.24	61.34	38.71
Free Cash Flow Per Share	1.22	1.06	0.78	0.59	0.59	0.37
Dividend Per Share	0.550	0.550	0.400	0.300	0.220	0.150
Dividend Growth	150.00%	37.50%	33.33%	36.36%	46.67%	25.00%
Gross Margin	99.87%	99.86%	99.81%	99.56%	99.50%	99.28%
Operating Margin	136.01%	74.09%	69.84%	67.32%	65.60%	62.63%
Profit Margin	97.33%	54.10%	51.27%	48.56%	47.55%	45.32%
Free Cash Flow Margin	52.82%	52.07%	50.57%	49.83%	65.63%	56.88%
EBITDA	328.79	158.12	113.06	84.37	61.59	42.89
EBITDA Margin	136.35%	74.24%	70.00%	67.55%	65.89%	63.02%
D&A For EBITDA	0.82	0.33	0.27	0.29	0.27	0.26
EBIT	327.97	157.79	112.79	84.08	61.31	42.63
EBIT Margin	136.01%	74.09%	69.84%	67.32%	65.60%	62.63%
Effective Tax Rate	29.59%	29.45%	28.93%	29.58%	29.54%	28.04%
Revenue as Reported	248.69	220.54	166.33	127.33	94.11	68.06
Advertising Expenses	-	3.74	2.89	2.52	1.95	0.32

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.